Biosimilars: FDA draft guidance addresses manufacturing changes
Regulatory NewsJoanne S. Eglovitch
Biologics License Application (BLA)Biologics/ biosimilars/ vaccinesBiotechnologyBsUFAComplianceManufacturingQuality Assurance and ControlRegulatory Intelligence/PolicyUnited States